Phase 3 Sleep Apnea Clinical Trials
12 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–12 of 12 trials
Recruiting
Phase 3
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
Obstructive Sleep Apnea
Amgen250 enrolled38 locationsNCT07226765
Recruiting
Phase 3
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
ObesityObstructive Sleep Apnea
Amgen250 enrolled47 locationsNCT07225686
Recruiting
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
ObesityOverweightSleep Apnea, Obstructive
Eli Lilly and Company800 enrolled123 locationsNCT07369011
Recruiting
Phase 3
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
ObesityOSA - Obstructive Sleep Apnea
Hangzhou Sciwind Biosciences Co., Ltd.140 enrolled1 locationNCT07434050
Recruiting
Phase 3
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
ObesityOSA - Obstructive Sleep Apnea
Hangzhou Sciwind Biosciences Co., Ltd.140 enrolled1 locationNCT07387094
Recruiting
Phase 3
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
Bstructive Sleep Apnea (OSA) and Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.140 enrolled1 locationNCT06974851
Recruiting
Phase 3
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
ObesitySleep ApneaObstructive
Innovent Biologics (Suzhou) Co. Ltd.260 enrolled1 locationNCT06931028
Recruiting
Phase 3
OROPHARYNGEAL MYOFUNCTIONAL THERAPY IN OBSTRUCTIVE SLEEP APNEA
Obstructive Sleep Apnea
Instituto de Investigación Marqués de Valdecilla30 enrolled1 locationNCT06681974
Withdrawn
Phase 3
The effect of non-steroidal anti-inflammatory drugs on hormones and metabolism in overweight men with low testosterone and obstructive sleep apnea (optional partner participation)
Hypogonadism- low testosteroneObstructive Sleep Apnea
Woolcock20 enrolled1 locationACTRN12612000536864
Completed
Phase 2Phase 3
Diet Exercise and ARmodafinil for treatment resistant sleep apnea (DEAR)
ObesitySleep Apnea
Woolcock Institute for Medical Research130 enrolled1 locationACTRN12611000847910
Completed
Phase 3
Sleep Apnea CardioVascular Endpoints study – An investigation of continuous positive airway pressure for the treatment of obstructive sleep apnea to prevent cardiovascular disease.
Obstructive Sleep ApneaCardiovascular Disease
Respironics Sleep and Respiratory Research Foundation2,500 enrolled25 locationsACTRN12608000409370
Completed
Phase 3
A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program
Obstructive Sleep Apnea (OSA)
The Woolcock Institute of Medical Research60 enrolled1 locationACTRN12606000404527